Founders Capital Management, LLC Abb Vie Inc. Transaction History

Founders Capital Management, LLC

$571 Million
Q3 2024

A detailed history of Founders Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Founders Capital Management, LLC holds 23,394 shares of ABBV stock, worth $4.05 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares

23,394

Previous 23,726 1.4%

Holding current value

$4.05 Million

Previous $4.07 Million 13.52%

% of portfolio

0.81%

Previous 0.74%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$163.84 - $199.33 $54,394 - $66,177	-332 Reduced 1.4%	23,394 $4.62 Million
Q1 2024 Apr 22, 2024	BUY	$159.82 - $182.1 $127,856 - $145,680	800 Added 3.49%	23,726 $4.32 Million
Q3 2023 Oct 24, 2023	BUY	$133.59 - $154.65 $9,351 - $10,825	70 Added 0.31%	22,926 $3.42 Million
Q4 2021 Jan 27, 2022	SELL	$107.43 - $135.93 $27,931 - $35,341	-260 Reduced 1.12%	22,856 $3.1 Million
Q3 2021 Oct 21, 2021	BUY	$106.4 - $120.78 $44,156 - $50,123	415 Added 1.83%	23,116 $2.49 Million
Q2 2021 Jul 15, 2021	BUY	$105.21 - $117.21 $27,354 - $30,474	260 Added 1.16%	22,701 $2.56 Million
Q3 2020 Oct 19, 2020	SELL	$85.91 - $100.83 $10,309 - $12,099	-120 Reduced 0.53%	22,441 $1.97 Million
Q1 2020 Apr 20, 2020	SELL	$64.5 - $97.79 $67,338 - $102,092	-1,044 Reduced 4.42%	22,561 $1.72 Million
Q2 2019 Jul 11, 2019	BUY	$65.7 - $83.98 $34,623 - $44,257	527 Added 2.28%	23,605 $1.72 Million
Q1 2019 Apr 16, 2019	SELL	$77.14 - $90.79 $8,099 - $9,532	-105 Reduced 0.45%	23,078 $1.86 Million
Q4 2018 Jan 15, 2019	SELL	$77.85 - $96.01 $174,695 - $215,446	-2,244 Reduced 8.83%	23,183 $2.14 Million
Q3 2018 Oct 11, 2018	BUY	$88.91 - $98.84 $35,564 - $39,536	400 Added 1.6%	25,427 $2.41 Million
Q2 2018 Jul 09, 2018	SELL	$89.78 - $106.23 $42,645 - $50,459	-475 Reduced 1.86%	25,027 $2.32 Million
Q1 2018 Apr 04, 2018	SELL	$92.01 - $123.21 $759,818 - $1.02 Million	-8,258 Reduced 24.46%	25,502 $2.33 Million
Q4 2017 Jan 10, 2018	SELL	$89.56 - $98.21 $44,600 - $48,908	-498 Reduced 1.45%	33,760 $3.27 Million
Q3 2017 Oct 24, 2017	SELL	$69.85 - $89.22 $12,503 - $15,970	-179 Reduced 0.52%	34,258 $3.04 Million
Q3 2017 Oct 16, 2017	BUY	$69.85 - $89.22 $2.41 Million - $3.07 Million	34,437	34,437 $3.04 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $306B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Founders Capital Management, LLC with notifications on news.

Account

Founders Capital Management, LLC Abb Vie Inc. Transaction History